Pharmacokinetics of Micafungin (Mycamine) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

Trial Profile

Pharmacokinetics of Micafungin (Mycamine) Given Intravenously as Therapy to Patients With an Invasive Fungal Infection in the Intensive Care Unit - a Search for Co-variates

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Dec 2015

At a glance

  • Drugs Micafungin (Primary)
  • Indications Mycoses
  • Focus Pharmacokinetics
  • Acronyms MIMIC
  • Most Recent Events

    • 05 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top